Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma

Objectives: The aim of our study was to evaluate the outcome of alternative sequences of sunitinib followed by sorafenib versus sorafenib followed by sunitinib therapies in patients with metastatic renal cell carcinoma (mRCC). Materials and Methods: This single-center study analyzed patients with mR...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlemmer, Marcus, Spek, Annabel, Rodler, Severin, Schott, Melanie, Casuscelli, Jozefina, Staehler, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516620/
https://www.ncbi.nlm.nih.gov/pubmed/31131167
http://dx.doi.org/10.7759/cureus.4244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516620/
https://www.ncbi.nlm.nih.gov/pubmed/31131167
http://dx.doi.org/10.7759/cureus.4244

Ejemplares similares